Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03540745 · ClinicalTrials.gov registry record · NA
Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders
A NA study of Depression and Anxiety, sponsored by University of Arizona.
- Active
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT03540745 is a NA study of Depression and Anxiety that is active but no longer recruiting, run by University of Arizona. The registered enrollment target is 14 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03540745, a NA study of Depression and Anxiety, is active but no longer recruiting, sponsored by University of Arizona.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to determine whether Nexalin Trans-cranial Electrical Stimulation (TES) is a viable adjunctive treatment of substance use treatments.
Conditions Studied
Interventions
- DEVICE TES Treatment
- DEVICE TES-SHAM Treatment
Study Locations (1)
New Jersey
- Carrier Clinic - Belle Mead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-06-11 |
| Est. Completion | 2019-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03540745
The ClinicalTrials.gov registry entry for NCT03540745 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which TES Treatment is the first listed.
NCT03540745 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT03540745 about?
NCT03540745 is a clinical study titled "Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders". The purpose of this research study is to determine whether Nexalin Trans-cranial Electrical Stimulation (TES) is a viable adjunctive treatment of substance use treatments.
What is the current status of trial NCT03540745?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2018-06-11. Estimated completion is 2019-11.
What conditions does trial NCT03540745 study?
This clinical trial studies the following conditions: Depression, Anxiety, Insomnia, Substance Abuse.
What interventions are being tested in trial NCT03540745?
The interventions under investigation include: TES Treatment (DEVICE), TES-SHAM Treatment (DEVICE).
Who is sponsoring clinical trial NCT03540745?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03540745 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.